Cargando…
Efficacy and safety of concurrent anti-tuberculosis treatment and chemotherapy in lung cancer patients with co-existent tuberculosis
BACKGROUND: This retrospective study evaluated the safety and efficacy of concurrent anti-tuberculosis (TB) and chemotherapy treatment in patients with advanced lung cancer and active TB. METHODS: We retrospectively analyzed patients who were first diagnosed with advanced lung cancer and received fi...
Autores principales: | Ye, Mei-Feng, Su, Shan, Huang, Zhi-Hao, Zou, Jian-Jun, Su, Duo-Hua, Chen, Xiao-Hui, Zeng, Long-Feng, Liao, Wei-Xiang, Huang, Hui-Yi, Zeng, Yun-Yun, Cen, Wen-Chang, Zhang, Xian-Lan, Liao, Chun-Xin, Zhang, Jian, Zhang, Yan-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576042/ https://www.ncbi.nlm.nih.gov/pubmed/33240992 http://dx.doi.org/10.21037/atm-20-5964 |
Ejemplares similares
-
Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage
por: Su, Shan, et al.
Publicado: (2021) -
Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing
por: Su, Shan, et al.
Publicado: (2019) -
Efficacy of adjuvant chemotherapy/maintenance chemotherapy after induction chemotherapy and concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Experiences of two centers
por: Tao, Hao‐Yun, et al.
Publicado: (2022) -
Concurrent Tuberculosis and Influenza, South Korea
por: Noh, Ji Yun, et al.
Publicado: (2013) -
The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Zou, Rui, et al.
Publicado: (2021)